Sagimet Biosciences Inc.

SGMT | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.30

+$0.50 (+4.63%)

Sep 22, 2026, 10:57 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022
Cash & Equivalents	165.9M	36.63M	35.02M	32.5M	42.33M	64.72M	75.84M	77.01M	95.96M	176.78M	75.14M	101.84M	18.51M	12.34M	158K
Short-Term Investments	74.23M	67.91M	78.1M	84.2M	83.08M	79.85M	75.41M	75.47M	70.41M	16.93M	19.76M	n/a	n/a	12.92M	32.19M
Long-Term Investments	n/a	n/a	n/a	8.81M	10.06M	n/a	7.41M	17.47M	22.12M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	17.49M	n/a	n/a	247K	n/a	62K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27K	27K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	650K	481K	253K	793K	888K	463K	407K	130K	108K	397K	77K	2.74M	1.42M	34K
Total Current Assets	243.99M	107.72M	116.4M	119.23M	127.2M	146.07M	152.77M	157.19M	166.75M	194.49M	96.65M	102.82M	21.35M	27.05M	32.79M
Property-Plant & Equipment	1.95M	39K	78K	115K	152K	38K	77K	114K	151K	37K	73K	109K	144K	178K	212K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	19.44M	39K	78K	9.17M	10.21M	100K	7.49M	17.59M	22.27M	37K	73K	109K	144K	205K	239K
Total Assets	263.43M	107.76M	116.48M	128.4M	137.41M	146.17M	160.26M	174.78M	189.02M	194.53M	96.72M	102.93M	21.5M	27.25M	33.03M
Account Payables	1.13M	2.3M	1.31M	4.24M	1.92M	3.22M	1.43M	1.15M	1.99M	531K	186K	1.7M	2.72M	1.46M	1.13M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	115K	n/a	n/a	n/a	n/a	n/a	26K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	15K	27K	3.5M	1K	16K	5K	11K	10K	3.64M	556K	95K	103K	1.03M	57K
Total Current Liabilities	5.42M	5.3M	5.1M	9.15M	7.25M	7.18M	4.45M	4.09M	5.73M	4.51M	5.65M	5.05M	5.29M	5.29M	5.28M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	214.63M	n/a	214.62M
Total Long-Term Liabilities	1.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	214.63M	39K	214.7M
Total Liabilities	7.28M	5.3M	5.1M	9.15M	7.25M	7.18M	4.45M	4.09M	5.73M	4.51M	5.65M	5.05M	219.91M	5.33M	219.98M
Total Debt	1.94M	39K	78K	115K	152K	39K	78K	116K	153K	26K	65K	103K	140K	176K	211K
Book Value	256.16M	102.46M	111.38M	119.26M	130.16M	138.99M	155.81M	170.68M	183.29M	190.02M	91.07M	97.88M	-198.41M	21.93M	-186.95M
Book Value Per Share	4.82	3.15	3.42	3.67	4.04	4.32	4.84	5.31	5.74	6.54	5.01	5.38	-8.95	0.99	-8.43
Common Stock	6K	3K	3K	3K	3K	3K	3K	3K	3K	3K	2K	2K	1K	1K	1K
Retained Earnings	-370.95M	-357M	-346.35M	-336.78M	-323.87M	-313.49M	-295.31M	-279.11M	-264.49M	-256.37M	-249.74M	-241.59M	-235.24M	-228.46M	-221.87M
Comprehensive Income	-77K	8K	120K	117K	76K	121K	230K	441K	-23K	7K	30K	0	n/a	-13K	-84K
Shareholders Equity	256.16M	102.46M	111.38M	119.26M	130.16M	138.99M	155.81M	170.68M	183.29M	190.02M	91.07M	97.88M	-198.41M	21.93M	-186.95M
Total Investments	74.23M	67.91M	78.1M	93M	93.14M	79.85M	82.82M	92.94M	92.53M	16.93M	19.76M	n/a	n/a	12.92M	32.19M